| 摘要 |
<p><P>PROBLEM TO BE SOLVED: To provide a new antibody against CCR5 used as a therapeutic agent for AIDS. <P>SOLUTION: There is provided an antibody binding to human CCR5 comprising a variable heavy chain or variable light chain, characterized in that the variable heavy chain comprises CDR sequences CDR1, CDR2 and CDR3, all of which are selected from specific amino-acid sequences, wherein CDRs are selected independently of each other or are chimeric, humanized variants or fragments of the antibody. <P>COPYRIGHT: (C)2011,JPO&INPIT</p> |
